Onto Innovation (ONTO) Financials

$95.88 +3.86 (+4.19%)

Closing price 03:59 PM Eastern

Extended Trading

$95.60 -0.27 (-0.29%)

As of 07:46 PM Eastern

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	12/26/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/26/2015
Net Income / (Loss) Attributable to Common Shareholders	202	121	223	142	31	1.91	45	33	44	2.91
Consolidated Net Income / (Loss)	202	121	223	142	31	1.91	45	33	44	2.91
Net Income / (Loss) Continuing Operations	202	121	223	142	31	1.91	45	33	44	2.91
Total Pre-Tax Income	220	133	242	156	-27	-0.60	53	60	29	5.57
Total Operating Income	187	116	237	156	-27	-5.04	51	59	29	4.97
Total Gross Profit	515	420	539	429	278	135	148	135	114	90
Total Revenue	987	816	1,005	789	556	306	274	255	221	187
Operating Revenue	987	816	1,005	789	556	306	274	255	221	187
Total Cost of Revenue	472	396	466	360	278	171	126	121	107	98
Operating Cost of Revenue	472	396	466	360	278	171	126	121	107	98
Total Operating Expenses	328	304	303	273	252	140	97	75	85	85
Selling, General & Admin Expense	86	83	70	68	65	53	34	28	23	22
Marketing Expense	76	62	66	57	48	28	22	21	30	28
Research & Development Expense	117	104	112	96	85	48	40	38	31	33
Amortization Expense	49	55	55	51	54	10	1.53	1.94	0.02	0.11
Total Other Income / (Expense), net	33	17	4.87	-0.73	0.19	4.45	2.26	0.51	0.04	0.60
Interest & Investment Income	33	20	5.01	1.16	2.90	3.67	2.21	0.97	0.04	0.07
Other Income / (Expense), net	-0.15	-3.85	-0.14	-1.89	-2.71	0.78	0.06	-0.46	0.29	0.81
Income Tax Expense	19	11	18	13	-4.16	-2.51	8.25	27	-15	2.66
Basic Earnings per Share	$4.09	$2.47	$4.52	$2.89	$0.63	$0.06	$1.77	$1.30	$1.79	$0.12
Weighted Average Basic Shares Outstanding	49.34M	48.97M	49.42M	49.24M	49.14M	29.73M	25.47M	25.33M	24.66M	24.06M
Diluted Earnings per Share	$4.06	$2.46	$4.49	$2.86	$0.63	$0.06	$1.74	$1.27	$1.75	$0.12
Weighted Average Diluted Shares Outstanding	49.66M	49.32M	49.76M	49.73M	49.48M	30.01M	25.90M	25.87M	25.15M	24.38M
Weighted Average Basic & Diluted Shares Outstanding	49.27M	49.13M	48.75M	49.36M	48.88M	50.28M	24.10M	25.40M	24.60M	24.20M

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	64	49	53	53	47	30	36	26	29	66	52
Consolidated Net Income / (Loss)	64	49	53	53	47	30	36	26	29	66	52
Net Income / (Loss) Continuing Operations	64	49	53	53	47	30	36	26	29	66	52
Total Pre-Tax Income	72	51	61	57	51	34	39	28	32	66	60
Total Operating Income	63	42	53	49	43	28	34	25	29	61	59
Total Gross Profit	143	132	136	128	118	108	107	100	105	137	139
Total Revenue	267	264	252	242	229	219	207	191	199	253	254
Operating Revenue	267	264	252	242	229	219	207	191	199	253	254
Total Cost of Revenue	123	132	116	114	111	111	100	90	94	116	115
Operating Cost of Revenue	123	132	116	114	111	111	100	90	94	116	115
Total Operating Expenses	80	90	83	79	76	80	73	76	76	76	80
Selling, General & Admin Expense	24	26	22	20	18	27	18	19	19	18	17
Marketing Expense	20	19	19	19	18	15	15	16	16	16	17
Research & Development Expense	28	35	28	27	27	24	26	27	27	28	32
Amortization Expense	8.45	10	13	13	13	13	14	14	14	14	14
Total Other Income / (Expense), net	8.52	8.81	7.94	8.44	8.15	5.60	4.69	3.05	3.17	4.34	0.55
Interest & Investment Income	9.27	8.97	8.67	8.50	7.36	6.46	5.69	4.76	3.45	2.46	1.52
Other Income / (Expense), net	-0.74	-0.15	-0.72	-0.06	0.79	-0.86	-1.00	-1.71	-0.28	1.88	-0.96
Income Tax Expense	7.56	2.45	7.96	4.32	4.04	3.52	2.81	1.96	3.13	-0.66	7.65
Basic Earnings per Share	$1.30	$1.00	$1.07	$1.07	$0.95	$0.61	$0.73	$0.53	$0.60	$1.35	$1.05
Weighted Average Basic Shares Outstanding	49.18M	49.34M	49.43M	49.34M	49.23M	48.97M	49.04M	48.98M	48.79M	49.42M	49.68M
Diluted Earnings per Share	$1.30	$0.98	$1.07	$1.07	$0.94	$0.61	$0.73	$0.53	$0.59	$1.34	$1.05
Weighted Average Diluted Shares Outstanding	49.41M	49.66M	49.69M	49.67M	49.64M	49.32M	49.40M	49.27M	49.11M	49.76M	49.95M
Weighted Average Basic & Diluted Shares Outstanding	48.87M	49.27M	49.39M	49.38M	49.28M	49.13M	49.08M	49.07M	48.95M	48.75M	49.52M

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	12/26/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/26/2015
Net Change in Cash & Equivalents	-21	82	24	33	-52	18	45	30	8.91	3.48
Net Cash From Operating Activities	246	172	137	175	106	18	35	64	46	1.57
Net Cash From Continuing Operating Activities	246	195	148	175	50	18	35	64	46	1.57
Net Income / (Loss) Continuing Operations	202	121	223	142	31	1.91	45	33	44	2.91
Consolidated Net Income / (Loss)	202	121	223	142	31	1.91	45	33	44	2.91
Depreciation Expense	13	12	9.38	14	14	5.97	4.85	3.99	8.30	9.08
Amortization Expense	49	55	55	52	64	26	1.53	1.94	-	-
Non-Cash Adjustments To Reconcile Net Income	53	39	40	30	37	24	11	9.87	11	9.02
Changes in Operating Assets and Liabilities, net	-71	-32	-180	-63	-97	-39	-27	15	-17	-19
Net Cash From Investing Activities	-227	-103	-56	-142	49	4.10	34	-33	-42	1.95
Net Cash From Continuing Investing Activities	-227	-103	-56	-142	-49	4.10	34	-33	-42	1.95
Purchase of Property, Plant & Equipment	-32	-23	-18	-12	-3.83	-6.80	-7.54	-10	-4.00	-1.85
Acquisitions	-27	0.00	-4.64	-24	0.00	0.00	-	-1.00	0.00	-
Purchase of Investments	-709	-480	-371	-361	-313	-127	-140	-165	-83	-41
Sale of Property, Plant & Equipment	0.00	2.80	0.00	0.00	-	-	-	-	0.00	-
Sale and/or Maturity of Investments	541	397	339	255	265	94	186	143	45	45
Net Cash From Financing Activities	-36	-9.48	-68	2.67	-54	-4.20	-24	-2.55	5.27	0.22
Net Cash From Continuing Financing Activities	-36	-9.48	-68	2.67	-54	-4.20	-24	-2.55	5.27	0.22
Repurchase of Common Equity	-25	-3.20	-65	0.00	-52	-0.74	-21	-1.03	0.00	-1.72
Issuance of Common Equity	9.18	5.29	8.07	10	2.92	0.84	0.62	0.62	8.45	3.97
Other Financing Activities, net	-20	-12	-11	-7.40	-4.62	-4.30	-3.46	-2.15	-2.86	-1.18
Effect of Exchange Rate Changes	-4.02	-	-	-	-	0.23	-0.34	0.81	0.08	-0.26
Cash Income Taxes Paid	36	34	59	24	0.00	-3.85	4.30	15	3.77	-0.83

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-9.22	24	16	-18	-43	51	-18	-6.23	55	-25	39
Net Cash From Operating Activities	92	56	67	65	57	62	29	32	50	49	32
Net Cash From Continuing Operating Activities	92	56	67	65	57	84	29	29	53	61	32
Net Income / (Loss) Continuing Operations	64	49	53	53	47	30	36	26	29	66	52
Consolidated Net Income / (Loss)	64	49	53	53	47	30	36	26	29	66	52
Depreciation Expense	4.40	2.05	3.90	3.53	3.39	3.37	3.20	2.90	2.92	2.40	2.31
Amortization Expense	6.91	10	13	13	13	13	14	14	14	14	14
Non-Cash Adjustments To Reconcile Net Income	9.52	25	9.81	9.85	7.99	9.49	7.64	9.30	12	6.70	14
Changes in Operating Assets and Liabilities, net	7.06	-30	-13	-14	-14	28	-32	-23	-4.64	-29	-50
Net Cash From Investing Activities	-22	-4.10	-57	-74	-92	-37	-43	-9.66	-13	-26	3.98
Net Cash From Continuing Investing Activities	-22	-4.10	-57	-74	-92	-37	-43	-36	13	-36	13
Purchase of Property, Plant & Equipment	-8.23	-4.63	-8.05	-12	-6.98	-2.46	-7.65	-4.61	-7.86	-8.62	-2.88
Acquisitions	-0.06	-	-	-	-	-	-	-	-	-9.22	-
Purchase of Investments	-209	-171	-143	-187	-208	-120	-151	-121	-89	-82	-115
Sale and/or Maturity of Investments	203	198	95	125	123	83	115	89	110	64	126
Other Investing Activities, net	-8.00	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-80	-26	3.95	-8.87	-5.07	-0.39	-0.92	1.31	-9.47	-50	-12
Net Cash From Continuing Financing Activities	-80	-26	3.95	-8.87	-5.07	-0.39	-0.92	1.31	-9.47	-50	-12
Repurchase of Common Equity	-75	-25	-	-	0.00	-	-	-	-3.20	-54	-12
Issuance of Common Equity	4.18	-	5.16	-0.00	4.02	-	-	5.29	0.00	3.57	-
Other Financing Activities, net	-8.68	-0.60	-1.22	-8.87	-9.09	-0.39	-0.92	-3.98	-6.27	-0.31	-0.23
Effect of Exchange Rate Changes	0.13	-2.02	-	-	-2.86	-	-2.03	-	-	-	-
Cash Income Taxes Paid	0.77	5.27	8.71	21	0.92	5.17	10	18	0.81	12	14

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	12/26/2020	12/31/2019	12/31/2018	12/30/2017	12/31/2016	12/26/2015
Total Assets	2,117	1,910	1,795	1,650	1,468	1,449	418	310	288	236
Total Current Assets	1,478	1,283	1,135	948	732	642	351	240	216	178
Cash & Equivalents	213	234	176	170	137	131	112	35	47	38
Short-Term Investments	639	464	372	342	237	190	63	82	83	45
Accounts Receivable	308	227	241	177	149	124	64	62	39	38
Inventories, net	287	328	324	243	191	176	97	54	41	51
Prepaid Expenses	30	31	21	16	17	22	15	6.23	5.67	6.59
Plant, Property, & Equipment, net	124	104	92	82	88	98	19	45	44	44
Total Noncurrent Assets	516	523	568	620	649	708	48	25	27	13
Goodwill	330	316	316	316	307	307	22	10	8.94	9.42
Intangible Assets	127	167	222	277	318	372	7.45	2.21	0.41	1.87
Noncurrent Deferred & Refundable Income Taxes	43	19	4.78	4.82	2.24	1.46	13	12	17	1.12
Other Noncurrent Operating Assets	15	21	25	22	21	28	5.51	0.41	0.47	0.53
Total Liabilities & Shareholders' Equity	2,117	1,910	1,795	1,650	1,468	1,449	418	310	288	236
Total Liabilities	191	173	198	224	203	185	56	47	44	48
Total Current Liabilities	170	148	161	155	120	86	45	44	42	45
Accounts Payable	56	50	55	53	40	28	17	14	11	12
Accrued Expenses	50	42	49	43	37	26	14	-	-	-
Current Deferred Revenue	34	25	30	30	14	13	6.77	7.41	9.17	13
Other Current Liabilities	30	31	27	28	28	19	7.54	7.25	8.05	8.88
Total Noncurrent Liabilities	21	25	38	69	83	99	11	3.22	2.03	3.00
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.00	7.37	40	56	67	0.00	0.18	0.02	0.52
Other Noncurrent Operating Liabilities	21	25	31	29	28	32	11	0.52	0.35	0.88
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,926	1,737	1,596	1,426	1,265	1,264	362	262	244	187
Total Preferred & Common Equity	1,926	1,737	1,596	1,426	1,265	1,264	362	262	244	187
Preferred Stock	0.00	0.00	0.00	-	0.00	-	-	0.00	0.00	0.00
Total Common Equity	1,926	1,737	1,596	1,426	1,265	1,264	362	262	244	187
Common Stock	1,275	1,262	1,244	1,256	1,234	1,269	370	255	272	259
Retained Earnings	665	482	363	169	26	-4.86	-6.77	9.11	-22	-66
Accumulated Other Comprehensive Income / (Loss)	-14	-7.90	-10	1.32	4.57	-0.60	-1.26	-2.12	-6.05	-5.20

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	10/1/2022
Total Assets	2,115	2,073	2,005	1,953	1,862	1,821	1,803	1,788
Total Current Assets	1,469	1,458	1,385	1,333	1,221	1,183	1,155	1,123
Cash & Equivalents	204	189	173	191	207	224	230	200
Short-Term Investments	647	667	613	550	423	385	353	352
Accounts Receivable	292	254	238	232	210	188	210	236
Inventories, net	293	308	320	330	346	352	338	308
Prepaid Expenses	34	41	42	31	36	34	24	27
Plant, Property, & Equipment, net	127	120	115	107	104	100	98	84
Total Noncurrent Assets	519	495	505	514	537	538	550	581
Goodwill	330	316	316	316	316	316	316	316
Intangible Assets	119	128	141	154	181	195	208	236
Noncurrent Deferred & Refundable Income Taxes	47	35	29	24	18	8.32	4.79	4.29
Other Noncurrent Operating Assets	23	17	18	19	22	19	21	25
Total Liabilities & Shareholders' Equity	2,115	2,073	2,005	1,953	1,862	1,821	1,803	1,788
Total Liabilities	195	170	174	172	166	164	178	218
Total Current Liabilities	174	145	148	147	136	137	148	170
Accounts Payable	55	48	51	56	44	50	54	64
Accrued Expenses	42	44	40	35	39	36	38	45
Current Deferred Revenue	39	27	28	26	23	24	28	29
Other Current Liabilities	38	26	28	30	29	27	29	31
Total Noncurrent Liabilities	21	25	25	25	30	27	30	49
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	1.74	16
Other Noncurrent Operating Liabilities	21	25	25	25	30	27	28	33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,920	1,904	1,832	1,782	1,696	1,657	1,625	1,569
Total Preferred & Common Equity	1,920	1,904	1,832	1,782	1,696	1,657	1,625	1,569
Total Common Equity	1,920	1,904	1,832	1,782	1,696	1,657	1,625	1,569
Common Stock	1,260	1,275	1,263	1,263	1,257	1,251	1,242	1,260
Retained Earnings	671	635	582	529	452	416	390	326
Accumulated Other Comprehensive Income / (Loss)	-12	-6.33	-13	-11	-13	-11	-7.53	-16

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	12/26/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/26/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.01%	-18.83%	27.42%	41.76%	81.92%	11.73%	7.33%	15.36%	18.02%	12.57%
EBITDA Growth	38.92%	-40.43%	36.48%	351.62%	77.60%	-52.16%	-11.18%	71.87%	153.55%	1,082.87%
EBIT Growth	66.59%	-52.56%	53.10%	625.84%	-589.30%	-108.34%	-13.07%	100.21%	407.86%	151.30%
NOPAT Growth	61.36%	-51.53%	53.02%	865.84%	-428.99%	-108.17%	32.36%	-25.81%	1,594.87%	131.81%
Net Income Growth	66.45%	-45.75%	56.89%	358.82%	1,524.35%	-95.76%	37.03%	-25.27%	1,415.83%	109.34%
EPS Growth	65.04%	-45.21%	56.99%	353.97%	950.00%	-96.55%	37.01%	-27.43%	1,358.33%	109.23%
Operating Cash Flow Growth	42.86%	25.80%	-22.01%	65.38%	484.06%	-48.29%	-45.31%	40.46%	2,808.02%	347.40%
Free Cash Flow Firm Growth	17.54%	36.62%	-28.85%	250.00%	104.48%	-44,268.62%	58.67%	-96.85%	666.48%	-156.35%
Invested Capital Growth	3.35%	-0.95%	14.64%	2.66%	-5.59%	405.20%	28.52%	27.71%	9.18%	9.07%
Revenue Q/Q Growth	4.78%	-4.05%	2.83%	9.82%	6.62%	44.55%	-15.02%	6.48%	8.05%	1.62%
EBITDA Q/Q Growth	4.34%	-16.41%	4.26%	67.74%	-34.65%	57.65%	-39.27%	60.93%	34.99%	33.37%
EBIT Q/Q Growth	8.68%	-24.15%	5.96%	136.12%	-117.36%	-130.08%	-43.79%	77.38%	52.85%	80.25%
NOPAT Q/Q Growth	9.74%	-25.55%	7.69%	126.37%	-134.15%	-125.82%	-26.55%	-28.13%	180.41%	4,256.71%
Net Income Q/Q Growth	10.10%	-22.86%	9.55%	23.22%	567.17%	-90.02%	-23.73%	-28.55%	182.86%	3,577.22%
EPS Q/Q Growth	10.03%	-22.88%	10.05%	22.22%	226.00%	-90.91%	-26.89%	-29.83%	186.89%	0.00%
Operating Cash Flow Q/Q Growth	-2.22%	7.56%	0.36%	9.96%	60.33%	177.50%	-73.45%	137.95%	37.09%	-86.05%
Free Cash Flow Firm Q/Q Growth	-21.80%	25.17%	-13.84%	146.24%	104.83%	-1,087.42%	-97.60%	-88.43%	65.86%	-347.74%
Invested Capital Q/Q Growth	2.43%	-2.60%	3.15%	0.30%	-0.70%	374.61%	54.22%	8.37%	16.00%	1.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.19%	51.51%	53.64%	54.39%	50.04%	44.14%	54.16%	52.76%	51.61%	47.86%
EBITDA Margin	25.25%	21.99%	29.97%	27.98%	8.78%	9.00%	21.01%	25.39%	17.04%	7.93%
Operating Margin	18.95%	14.23%	23.55%	19.83%	-4.79%	-1.65%	18.66%	23.24%	13.16%	2.65%
EBIT Margin	18.94%	13.76%	23.54%	19.59%	-5.28%	-1.39%	18.68%	23.06%	13.29%	3.09%
Profit (Net Income) Margin	20.43%	14.85%	22.22%	18.04%	5.58%	0.62%	16.47%	12.90%	19.91%	1.55%
Tax Burden Percent	91.48%	91.38%	92.45%	91.44%	-115.47%	-319.93%	84.53%	55.03%	151.14%	52.17%
Interest Burden Percent	117.91%	118.14%	102.12%	100.75%	91.43%	14.00%	104.31%	101.65%	99.15%	96.23%
Effective Tax Rate	8.52%	8.62%	7.55%	8.56%	0.00%	0.00%	15.47%	44.97%	-51.14%	47.83%
Return on Invested Capital (ROIC)	16.21%	10.16%	22.29%	15.84%	-2.04%	-0.62%	26.00%	25.18%	40.33%	2.60%
ROIC Less NNEP Spread (ROIC-NNEP)	12.27%	7.74%	21.44%	15.99%	-16.36%	-2.82%	24.69%	24.95%	40.28%	2.23%
Return on Net Nonoperating Assets (RNNOA)	-5.19%	-2.89%	-7.51%	-5.26%	4.49%	0.86%	-11.55%	-12.17%	-19.90%	-1.01%
Return on Equity (ROE)	11.01%	7.27%	14.78%	10.58%	2.45%	0.23%	14.45%	13.00%	20.43%	1.58%
Cash Return on Invested Capital (CROIC)	12.91%	11.11%	8.65%	13.22%	3.72%	-134.53%	1.04%	0.84%	31.56%	-6.08%
Operating Return on Assets (OROA)	9.29%	6.06%	13.74%	9.91%	-2.01%	-0.46%	14.05%	19.69%	11.23%	2.52%
Return on Assets (ROA)	10.02%	6.54%	12.97%	9.13%	2.13%	0.20%	12.39%	11.02%	16.83%	1.27%
Return on Common Equity (ROCE)	11.01%	7.27%	14.78%	10.58%	2.45%	0.23%	14.45%	13.00%	20.43%	1.58%
Return on Equity Simple (ROE_SIMPLE)	10.47%	6.98%	13.99%	9.98%	2.45%	0.15%	12.46%	12.54%	18.06%	1.55%
Net Operating Profit after Tax (NOPAT)	171	106	219	143	-19	-3.53	43	33	44	2.59
NOPAT Margin	17.34%	13.00%	21.77%	18.13%	-3.36%	-1.15%	15.77%	12.79%	19.89%	1.38%
Net Nonoperating Expense Percent (NNEP)	3.94%	2.42%	0.85%	-0.15%	14.32%	2.20%	1.31%	0.23%	0.06%	0.37%
Return On Investment Capital (ROIC_SIMPLE)	8.89%	6.11%	13.71%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	47.81%	48.49%	46.36%	45.61%	49.96%	55.86%	45.84%	47.24%	48.39%	52.14%
SG&A Expenses to Revenue	8.69%	10.19%	6.92%	8.61%	11.74%	17.33%	12.31%	10.93%	10.57%	11.98%
R&D to Revenue	11.83%	12.80%	11.14%	12.18%	15.20%	15.81%	14.59%	14.78%	14.22%	17.45%
Operating Expenses to Revenue	33.24%	37.28%	30.09%	34.56%	45.24%	45.79%	35.50%	29.52%	38.45%	45.20%
Earnings before Interest and Taxes (EBIT)	187	112	237	155	-29	-4.26	51	59	29	5.79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	249	179	301	221	49	28	58	65	38	15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.38	4.32	2.11	3.50	1.85	1.45	1.83	2.43	2.56	2.04
Price to Tangible Book Value (P/TBV)	5.74	5.99	3.19	5.99	3.67	3.13	1.99	2.55	2.66	2.17
Price to Revenue (P/Rev)	8.54	9.20	3.35	6.32	4.21	5.98	2.42	2.50	2.82	2.04
Price to Earnings (P/E)	41.80	61.94	15.10	35.04	75.58	957.73	14.68	19.38	14.18	131.47
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.39%	1.61%	6.62%	2.85%	1.32%	0.10%	6.81%	5.16%	7.05%	0.76%
Enterprise Value to Invested Capital (EV/IC)	7.06	6.55	2.69	4.89	2.21	1.60	2.61	3.58	4.34	2.87
Enterprise Value to Revenue (EV/Rev)	7.67	8.34	2.81	5.68	3.54	4.93	1.78	2.04	2.24	1.60
Enterprise Value to EBITDA (EV/EBITDA)	30.40	37.93	9.37	20.28	40.33	54.84	8.46	8.04	13.12	20.11
Enterprise Value to EBIT (EV/EBIT)	40.53	60.65	11.94	28.97	0.00	0.00	9.52	8.85	16.83	51.65
Enterprise Value to NOPAT (EV/NOPAT)	44.27	64.17	12.90	31.31	0.00	0.00	11.27	15.96	11.24	115.18
Enterprise Value to Operating Cash Flow (EV/OCF)	30.84	39.58	20.66	25.54	18.60	83.16	13.87	8.12	10.82	190.23
Enterprise Value to Free Cash Flow (EV/FCFF)	55.57	58.68	33.26	37.52	57.82	0.00	282.69	479.93	14.37	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.42	-0.37	-0.35	-0.33	-0.27	-0.30	-0.47	-0.49	-0.49	-0.46
Leverage Ratio	1.10	1.11	1.14	1.16	1.15	1.15	1.17	1.18	1.21	1.25
Compound Leverage Factor	1.30	1.31	1.16	1.17	1.05	0.16	1.22	1.20	1.20	1.20
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	28.39	27.69	12.12	14.88	7.75	6.60	8.99	10.34	10.23	5.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.69	8.69	7.07	6.14	6.09	7.48	7.80	5.45	5.15	3.94
Quick Ratio	6.82	6.26	4.92	4.46	4.35	5.18	5.32	4.07	4.03	2.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	136	116	85	119	34	-761	1.72	1.09	34	-6.07
Operating Cash Flow to CapEx	770.07%	869.74%	742.75%	1,455.94%	2,767.93%	266.77%	465.31%	628.51%	1,142.41%	85.10%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	120.72	-21.02
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	160.30	5.44
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	146.27	-0.95
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.44	0.58	0.51	0.38	0.33	0.75	0.85	0.85	0.82
Accounts Receivable Turnover	3.69	3.49	4.80	4.83	4.08	3.26	4.32	5.01	5.72	5.86
Inventory Turnover	1.54	1.21	1.64	1.66	1.51	1.25	1.66	2.52	2.33	2.23
Fixed Asset Turnover	8.68	8.34	11.55	9.28	5.97	5.22	8.60	5.73	4.98	3.98
Accounts Payable Turnover	8.90	7.58	8.64	7.69	8.19	7.64	8.14	9.56	9.30	8.93
Days Sales Outstanding (DSO)	98.84	104.68	76.00	75.52	89.50	112.07	84.42	72.91	63.79	62.29
Days Inventory Outstanding (DIO)	237.69	300.80	222.23	220.29	241.12	291.54	219.88	144.92	156.74	163.67
Days Payable Outstanding (DPO)	41.03	48.16	42.25	47.44	44.58	47.76	44.84	38.16	39.26	40.86
Cash Conversion Cycle (CCC)	295.49	357.32	255.98	248.38	286.04	355.85	259.47	179.67	181.27	185.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,074	1,039	1,049	915	891	944	187	145	114	104
Invested Capital Turnover	0.93	0.78	1.02	0.87	0.61	0.54	1.65	1.97	2.03	1.88
Increase / (Decrease) in Invested Capital	35	-9.92	134	24	-53	757	41	32	9.57	8.67
Enterprise Value (EV)	7,577	6,807	2,824	4,477	1,971	1,509	487	521	494	299
Market Capitalization	8,429	7,504	3,372	4,988	2,345	1,829	662	638	624	382
Book Value per Share	$38.99	$35.38	$32.24	$28.94	$25.90	$25.25	$14.94	$10.25	$9.78	$7.74
Tangible Book Value per Share	$29.73	$25.54	$21.37	$16.90	$13.10	$11.68	$13.71	$9.77	$9.41	$7.28
Total Capital	1,926	1,737	1,596	1,426	1,265	1,264	362	262	244	187
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-852	-698	-548	-511	-374	-320	-175	-117	-130	-83
Capital Expenditures (CapEx)	32	20	18	12	3.83	6.80	7.54	10	4.00	1.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)	455	438	427	282	238	236	131	79	44	50
Debt-free Net Working Capital (DFNWC)	1,307	1,136	974	794	612	556	306	196	174	133
Net Working Capital (NWC)	1,307	1,136	974	794	612	556	306	196	174	133
Net Nonoperating Expense (NNE)	-31	-15	-4.50	0.66	-50	-5.44	-1.91	-0.28	-0.06	-0.31
Net Nonoperating Obligations (NNO)	-852	-698	-548	-511	-374	-320	-175	-117	-130	-83
Total Depreciation and Amortization (D&A)	62	67	65	66	78	32	6.38	5.93	8.30	9.08
Debt-free, Cash-free Net Working Capital to Revenue	46.09%	53.65%	42.43%	35.77%	42.74%	77.05%	47.79%	30.96%	20.08%	26.59%
Debt-free Net Working Capital to Revenue	132.42%	139.18%	96.93%	100.59%	109.90%	181.74%	111.74%	76.84%	78.85%	70.93%
Net Working Capital to Revenue	132.42%	139.18%	96.93%	100.59%	109.90%	181.74%	111.74%	76.84%	78.85%	70.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.09	$2.47	$0.00	$2.89	$0.63	$0.06	$2.39	$1.19	$1.79	$0.12
Adjusted Weighted Average Basic Shares Outstanding	49.34M	48.97M	0.00	49.24M	49.14M	29.73M	24.12M	25.33M	24.66M	24.06M
Adjusted Diluted Earnings per Share	$4.06	$2.46	$0.00	$2.86	$0.63	$0.06	$2.34	$1.17	$1.75	$0.12
Adjusted Weighted Average Diluted Shares Outstanding	49.66M	49.32M	0.00	49.73M	49.48M	30.01M	24.60M	25.92M	25.15M	24.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.27M	49.13M	0.00	49.36M	48.88M	50.28M	24.46M	23.76M	25.16M	24.30M
Normalized Net Operating Profit after Tax (NOPAT)	171	106	219	143	-19	-3.53	43	25	20	3.31
Normalized NOPAT Margin	17.34%	13.00%	21.77%	18.13%	-3.36%	-1.15%	15.77%	9.99%	9.21%	1.77%
Pre Tax Income Margin	22.33%	16.25%	24.03%	19.73%	-4.83%	-0.20%	19.48%	23.44%	13.18%	2.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	103.11	20.02
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	154.30	8.98
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	89.07	13.63
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	140.27	2.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.72%	29.29%
Augmented Payout Ratio	12.43%	2.64%	29.22%	0.00%	167.61%	38.95%	46.72%	3.11%	0.72%	88.54%

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.50%	20.60%	21.73%	27.10%	14.90%	-13.59%	-18.51%	-25.61%	-17.48%	12.24%	26.75%
EBITDA Growth	26.09%	23.52%	38.63%	64.28%	31.95%	-44.41%	-32.83%	-45.23%	-39.12%	18.36%	25.41%
EBIT Growth	43.33%	54.57%	58.61%	111.17%	51.39%	-56.62%	-43.43%	-59.19%	-50.88%	26.72%	36.21%
NOPAT Growth	43.52%	59.83%	46.33%	95.77%	50.12%	-59.09%	-39.04%	-55.44%	-50.71%	32.82%	41.75%
Net Income Growth	36.80%	61.06%	47.83%	104.47%	61.18%	-54.23%	-31.27%	-49.79%	-45.49%	41.67%	43.26%
EPS Growth	38.30%	60.66%	46.58%	101.89%	59.32%	-54.48%	-30.48%	-48.54%	-44.86%	44.09%	43.84%
Operating Cash Flow Growth	61.00%	-9.07%	134.87%	106.07%	14.11%	24.43%	-10.02%	219.05%	10.14%	1.01%	-36.17%
Free Cash Flow Firm Growth	-29.50%	-84.10%	452.82%	213.41%	147.15%	148.84%	65.46%	-229.75%	-481.00%	-415.37%	-343.06%
Invested Capital Growth	2.73%	3.35%	-1.72%	-0.14%	-0.05%	-0.95%	4.90%	6.53%	11.90%	14.64%	11.48%
Revenue Q/Q Growth	1.01%	4.65%	4.08%	5.89%	4.56%	5.63%	8.67%	-4.27%	-21.36%	-0.39%	-0.80%
EBITDA Q/Q Growth	35.32%	-21.48%	6.02%	8.97%	36.15%	-11.87%	25.64%	-12.47%	-42.64%	6.49%	2.43%
EBIT Q/Q Growth	47.48%	-19.18%	7.33%	12.04%	59.05%	-17.07%	42.90%	-19.67%	-54.43%	8.14%	3.10%
NOPAT Q/Q Growth	39.68%	-12.39%	2.20%	14.75%	55.55%	-19.79%	36.73%	-12.01%	-57.61%	19.52%	-0.04%
Net Income Q/Q Growth	31.30%	-7.98%	0.19%	13.01%	54.58%	-15.54%	38.58%	-10.91%	-56.10%	26.81%	1.24%
EPS Q/Q Growth	32.65%	-8.41%	0.00%	13.83%	54.10%	-16.44%	37.74%	-10.17%	-55.97%	27.62%	1.94%
Operating Cash Flow Q/Q Growth	64.25%	-16.73%	2.98%	14.30%	-7.23%	115.10%	-9.64%	-36.71%	1.16%	55.55%	220.38%
Free Cash Flow Firm Q/Q Growth	401.64%	-91.32%	38.37%	17.03%	13.12%	292.61%	55.52%	51.35%	-17.18%	-36.22%	-324.62%
Invested Capital Q/Q Growth	-0.42%	2.43%	0.24%	0.48%	0.18%	-2.60%	1.85%	0.58%	-0.72%	3.15%	3.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.72%	50.17%	54.07%	52.92%	51.69%	49.33%	51.57%	52.69%	52.71%	54.18%	54.61%
EBITDA Margin	27.64%	20.63%	27.50%	27.00%	26.23%	20.15%	24.15%	20.89%	22.84%	31.32%	29.29%
Operating Margin	23.68%	16.09%	21.04%	20.15%	18.68%	12.90%	16.41%	13.01%	14.58%	24.17%	23.33%
EBIT Margin	23.40%	16.03%	20.76%	20.13%	19.02%	12.51%	15.93%	12.11%	14.44%	24.91%	22.95%
Profit (Net Income) Margin	24.04%	18.50%	21.03%	21.85%	20.47%	13.85%	17.32%	13.58%	14.59%	26.14%	20.54%
Tax Burden Percent	89.45%	95.21%	86.95%	92.46%	92.06%	89.60%	92.73%	92.97%	90.27%	101.01%	87.23%
Interest Burden Percent	114.85%	121.19%	116.56%	117.42%	116.91%	123.59%	117.25%	120.60%	111.99%	103.89%	102.60%
Effective Tax Rate	10.55%	4.79%	13.05%	7.54%	7.94%	10.40%	7.27%	7.03%	9.73%	-1.01%	12.77%
Return on Invested Capital (ROIC)	20.58%	14.32%	16.31%	15.98%	13.97%	9.03%	12.43%	10.69%	12.86%	25.00%	20.63%
ROIC Less NNEP Spread (ROIC-NNEP)	19.63%	13.24%	15.38%	14.86%	12.83%	8.23%	11.69%	10.20%	12.35%	24.17%	20.53%
Return on Net Nonoperating Assets (RNNOA)	-8.44%	-5.60%	-6.34%	-5.94%	-4.99%	-3.08%	-4.23%	-3.70%	-4.49%	-8.47%	-7.08%
Return on Equity (ROE)	12.14%	8.72%	9.96%	10.03%	8.98%	5.96%	8.19%	6.99%	8.37%	16.53%	13.55%
Cash Return on Invested Capital (CROIC)	15.16%	12.91%	16.49%	13.64%	11.50%	11.11%	8.90%	9.74%	8.23%	8.65%	10.22%
Operating Return on Assets (OROA)	11.79%	7.86%	9.94%	9.44%	8.56%	5.51%	7.42%	6.07%	7.89%	14.54%	13.23%
Return on Assets (ROA)	12.11%	9.07%	10.07%	10.25%	9.22%	6.10%	8.07%	6.80%	7.97%	15.26%	11.84%
Return on Common Equity (ROCE)	12.14%	8.72%	9.96%	10.03%	8.98%	5.96%	8.19%	6.99%	8.37%	16.53%	13.55%
Return on Equity Simple (ROE_SIMPLE)	11.40%	0.00%	9.62%	9.06%	7.80%	0.00%	9.26%	10.47%	12.25%	0.00%	12.99%
Net Operating Profit after Tax (NOPAT)	56	40	46	45	39	25	32	23	26	62	52
NOPAT Margin	21.18%	15.32%	18.30%	18.63%	17.19%	11.56%	15.22%	12.10%	13.16%	24.41%	20.35%
Net Nonoperating Expense Percent (NNEP)	0.96%	1.08%	0.93%	1.12%	1.13%	0.81%	0.74%	0.49%	0.51%	0.83%	0.10%
Return On Investment Capital (ROIC_SIMPLE)	2.94%	2.10%	-	-	-	1.46%	-	-	-	3.87%	-
Cost of Revenue to Revenue	46.28%	49.83%	45.93%	47.08%	48.31%	50.67%	48.43%	47.31%	47.29%	45.82%	45.39%
SG&A Expenses to Revenue	8.97%	9.68%	8.91%	8.37%	7.67%	12.34%	8.75%	9.84%	9.66%	7.10%	6.61%
R&D to Revenue	10.51%	13.22%	11.21%	11.16%	11.60%	10.98%	12.61%	14.18%	13.68%	10.99%	12.64%
Operating Expenses to Revenue	30.04%	34.08%	33.03%	32.77%	33.01%	36.43%	35.16%	39.68%	38.13%	30.01%	31.28%
Earnings before Interest and Taxes (EBIT)	62	42	52	49	44	27	33	23	29	63	58
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	74	54	69	65	60	44	50	40	45	79	74
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.13	4.38	5.59	5.91	4.99	4.32	3.69	3.44	2.64	2.11	2.03
Price to Tangible Book Value (P/TBV)	4.09	5.74	7.29	7.87	6.78	5.99	5.22	4.97	3.89	3.19	3.13
Price to Revenue (P/Rev)	5.87	8.54	11.29	12.06	10.51	9.20	7.36	6.35	4.45	3.35	3.26
Price to Earnings (P/E)	27.47	41.80	58.07	65.18	63.97	61.94	39.84	32.88	21.52	15.10	15.61
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.64%	2.39%	1.72%	1.53%	1.56%	1.61%	2.51%	3.04%	4.65%	6.62%	6.41%
Enterprise Value to Invested Capital (EV/IC)	4.83	7.06	9.33	9.60	7.83	6.55	5.28	4.86	3.55	2.69	2.59
Enterprise Value to Revenue (EV/Rev)	5.04	7.67	10.38	11.18	9.63	8.34	6.62	5.67	3.84	2.81	2.69
Enterprise Value to EBITDA (EV/EBITDA)	19.52	30.40	40.94	45.69	42.00	37.93	26.21	21.29	13.61	9.37	9.10
Enterprise Value to EBIT (EV/EBIT)	25.09	40.53	56.86	65.71	64.15	60.65	38.03	29.38	17.90	11.94	11.78
Enterprise Value to NOPAT (EV/NOPAT)	27.42	44.27	62.70	71.00	68.34	64.17	39.49	31.23	19.30	12.90	12.94
Enterprise Value to Operating Cash Flow (EV/OCF)	18.41	30.84	38.92	47.18	45.50	39.58	35.20	31.22	26.19	20.66	19.30
Enterprise Value to Free Cash Flow (EV/FCFF)	32.29	55.57	56.10	70.27	68.06	58.68	60.72	51.51	45.64	33.26	26.68
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.43	-0.42	-0.41	-0.40	-0.39	-0.37	-0.36	-0.36	-0.36	-0.35	-0.34
Leverage Ratio	1.10	1.10	1.09	1.10	1.10	1.11	1.12	1.12	1.14	1.14	1.15
Compound Leverage Factor	1.26	1.33	1.27	1.29	1.29	1.37	1.31	1.36	1.27	1.18	1.18
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	20.23	28.16	39.30	39.04	32.65	27.54	24.16	22.38	15.98	11.80	10.29
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.42	8.69	10.07	9.33	9.06	8.69	9.00	8.64	7.78	7.07	6.62
Quick Ratio	6.55	6.82	7.66	6.90	6.62	6.26	6.18	5.82	5.34	4.92	4.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	28	5.60	65	47	40	35	-18	-41	-84	-72	-53
Operating Cash Flow to CapEx	1,117.21%	1,210.53%	835.47%	532.92%	819.08%	2,500.45%	374.42%	687.67%	637.39%	574.25%	1,103.33%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.49	0.48	0.47	0.45	0.44	0.47	0.50	0.55	0.58	0.58
Accounts Receivable Turnover	3.92	3.69	4.07	4.22	3.83	3.49	3.82	4.25	4.63	4.80	4.71
Inventory Turnover	1.56	1.54	1.38	1.30	1.23	1.21	1.23	1.31	1.50	1.64	1.70
Fixed Asset Turnover	8.76	8.68	8.40	8.33	8.27	8.34	9.02	9.81	10.74	11.55	11.50
Accounts Payable Turnover	8.71	8.90	9.76	8.63	7.52	7.58	7.39	6.83	7.23	8.64	7.87
Days Sales Outstanding (DSO)	93.19	98.84	89.72	86.59	95.29	104.68	95.52	85.94	78.90	76.00	77.53
Days Inventory Outstanding (DIO)	234.20	237.69	264.57	281.28	295.85	300.80	297.78	277.67	243.98	222.23	214.18
Days Payable Outstanding (DPO)	41.89	41.03	37.38	42.28	48.55	48.16	49.37	53.48	50.49	42.25	46.38
Cash Conversion Cycle (CCC)	285.51	295.49	316.91	325.58	342.59	357.32	343.93	310.13	272.39	255.98	245.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,069	1,074	1,048	1,046	1,041	1,039	1,066	1,047	1,041	1,049	1,017
Invested Capital Turnover	0.97	0.93	0.89	0.86	0.81	0.78	0.82	0.88	0.98	1.02	1.01
Increase / (Decrease) in Invested Capital	28	35	-18	-1.47	-0.49	-9.92	50	64	111	134	105
Enterprise Value (EV)	5,164	7,577	9,780	10,033	8,147	6,807	5,627	5,091	3,701	2,824	2,629
Market Capitalization	6,014	8,429	10,636	10,819	8,888	7,504	6,257	5,701	4,285	3,372	3,182
Book Value per Share	$38.96	$38.99	$38.55	$37.17	$36.19	$35.38	$34.57	$33.85	$33.32	$32.24	$31.59
Tangible Book Value per Share	$29.85	$29.73	$29.56	$27.90	$26.64	$25.54	$24.45	$23.42	$22.57	$21.37	$20.48
Total Capital	1,920	1,926	1,904	1,832	1,782	1,737	1,696	1,657	1,625	1,596	1,569
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-851	-852	-855	-786	-741	-698	-630	-610	-584	-548	-553
Capital Expenditures (CapEx)	8.23	4.63	8.05	12	6.98	2.46	7.65	4.61	7.86	8.62	2.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)	444	455	458	451	445	438	456	437	423	427	400
Debt-free Net Working Capital (DFNWC)	1,295	1,307	1,313	1,237	1,186	1,136	1,085	1,046	1,007	974	953
Net Working Capital (NWC)	1,295	1,307	1,313	1,237	1,186	1,136	1,085	1,046	1,007	974	953
Net Nonoperating Expense (NNE)	-7.62	-8.39	-6.91	-7.80	-7.51	-5.01	-4.35	-2.83	-2.86	-4.38	-0.48
Net Nonoperating Obligations (NNO)	-851	-852	-855	-786	-741	-698	-630	-610	-584	-548	-553
Total Depreciation and Amortization (D&A)	11	12	17	17	17	17	17	17	17	16	16
Debt-free, Cash-free Net Working Capital to Revenue	43.33%	46.09%	48.59%	50.24%	52.61%	53.65%	53.60%	48.64%	43.94%	42.43%	40.96%
Debt-free Net Working Capital to Revenue	126.31%	132.42%	139.37%	137.85%	140.24%	139.18%	127.66%	116.58%	104.54%	96.93%	97.50%
Net Working Capital to Revenue	126.31%	132.42%	139.37%	137.85%	140.24%	139.18%	127.66%	116.58%	104.54%	96.93%	97.50%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.30	$1.00	$1.07	$1.07	$0.95	$0.61	$0.73	$0.53	$0.60	$1.35	$1.05
Adjusted Weighted Average Basic Shares Outstanding	49.18M	49.34M	49.43M	49.34M	49.23M	48.97M	49.04M	48.98M	48.79M	49.42M	49.68M
Adjusted Diluted Earnings per Share	$1.30	$0.98	$1.07	$1.07	$0.94	$0.61	$0.73	$0.53	$0.59	$1.34	$1.05
Adjusted Weighted Average Diluted Shares Outstanding	49.41M	49.66M	49.69M	49.67M	49.64M	49.32M	49.40M	49.27M	49.11M	49.76M	49.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.87M	49.27M	49.39M	49.38M	49.28M	49.13M	49.08M	49.07M	48.95M	48.75M	49.52M
Normalized Net Operating Profit after Tax (NOPAT)	56	40	46	45	39	25	32	23	26	43	52
Normalized NOPAT Margin	21.18%	15.32%	18.30%	18.63%	17.19%	11.56%	15.22%	12.10%	13.16%	16.92%	20.35%
Pre Tax Income Margin	26.88%	19.43%	24.19%	23.63%	22.24%	15.46%	18.68%	14.61%	16.17%	25.88%	23.54%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	45.72%	12.43%	0.00%	0.00%	0.00%	2.64%	36.24%	39.48%	34.39%	29.22%	5.66%

Frequently Asked Questions About Onto Innovation's Financials

When does Onto Innovation's financial year end?

According to the most recent income statement we have on file, Onto Innovation's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has Onto Innovation's net income changed over the last 9 years?

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $201.67 million in 2024, rising from $2.91 million in 2015. The previous period was $121.16 million in 2023. See where experts think Onto Innovation is headed by visiting Onto Innovation's forecast page.

What is Onto Innovation's operating income?

Onto Innovation's total operating income in 2024 was $187.10 million, based on the following breakdown:

Total Gross Profit: $515.31 million
Total Operating Expenses: $328.21 million

How has Onto Innovation revenue changed over the last 9 years?

Over the last 9 years, Onto Innovation's total revenue changed from $187.37 million in 2015 to $987.32 million in 2024, a change of 426.9%.

How much debt does Onto Innovation have?

Onto Innovation's total liabilities were at $191.21 million at the end of 2024, a 10.4% increase from 2023, and a 296.6% increase since 2015.

How much cash does Onto Innovation have?

In the past 9 years, Onto Innovation's cash and equivalents has ranged from $34.90 million in 2017 to $233.51 million in 2023, and is currently $212.95 million as of their latest financial filing in 2024.

How has Onto Innovation's book value per share changed over the last 9 years?

Over the last 9 years, Onto Innovation's book value per share changed from 7.74 in 2015 to 38.99 in 2024, a change of 403.5%.

Related Companies

This page (NYSE:ONTO) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Onto Innovation (ONTO) Financials

Frequently Asked Questions About Onto Innovation's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Onto Innovation (ONTO) Financials

Annual Income Statements for Onto Innovation

Quarterly Income Statements for Onto Innovation

Annual Cash Flow Statements for Onto Innovation

Quarterly Cash Flow Statements for Onto Innovation

Annual Balance Sheets for Onto Innovation

Quarterly Balance Sheets for Onto Innovation

Annual Metrics And Ratios for Onto Innovation

Quarterly Metrics And Ratios for Onto Innovation

Frequently Asked Questions About Onto Innovation's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools